Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 217684
Company: PYROS PHARMS
Company: PYROS PHARMS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| VIGAFYDE | VIGABATRIN | 100MG/ML | SOLUTION;ORAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 06/17/2024 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD; Orphan |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217684s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/217684Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/217684Orig1s000TOC.html |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 09/03/2025 | SUPPL-4 | Labeling-Package Insert, Labeling-Medication Guide, Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217684s002s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/217684Orig1s002, s004ltr.pdf | |
| 09/03/2025 | SUPPL-2 | Efficacy-New Route Of Administration |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217684s002s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/217684Orig1s002, s004ltr.pdf | |
| 09/12/2024 | SUPPL-1 | REMS - MODIFIED - D-N-A |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/217684Orig1s001ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 09/03/2025 | SUPPL-4 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217684s002s004lbl.pdf | |
| 09/03/2025 | SUPPL-4 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217684s002s004lbl.pdf | |
| 09/03/2025 | SUPPL-4 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217684s002s004lbl.pdf | |
| 09/03/2025 | SUPPL-2 | Efficacy-New Route Of Administration | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217684s002s004lbl.pdf | |
| 06/17/2024 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217684s000lbl.pdf |